86 related articles for article (PubMed ID: 15268980)
1. Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. I. Investigation of potential experimental and mechanistic explanations.
Ward KW; Azzarano LM; Evans CA; Smith BR
Xenobiotica; 2004 Apr; 34(4):353-66. PubMed ID: 15268980
[TBL] [Abstract][Full Text] [Related]
2. Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. II. Studies implicating transporter-mediated intestinal secretion.
Ward KW; Hardy LB; Kehler JR; Azzarano LM; Smith BR
Xenobiotica; 2004 Apr; 34(4):367-77. PubMed ID: 15268981
[TBL] [Abstract][Full Text] [Related]
3. Preclinical pharmacokinetics and interspecies scaling of a novel vitronectin receptor antagonist.
Ward KW; Azzarano LM; Bondinell WE; Cousins RD; Huffman WF; Jakas DR; Keenan RM; Ku TW; Lundberg D; Miller WH; Mumaw JA; Newlander KA; Pirhalla JL; Roethke TJ; Salyers KL; Souder PR; Stelman GJ; Smith BR
Drug Metab Dispos; 1999 Nov; 27(11):1232-41. PubMed ID: 10534306
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma.
Xu W; Sun J; Zhang TT; Ma B; Cui SM; Chen DW; He ZG
Acta Pharmacol Sin; 2006 Dec; 27(12):1642-6. PubMed ID: 17112421
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of in vitro and in vivo microdialysis recovery of SB-265123 using Intralipid and Encapsin as perfusates.
Ward KW; Medina SJ; Portelli ST; Mahar Doan KM; Spengler MD; Ben MM; Lundberg D; Levy MA; Chen EP
Biopharm Drug Dispos; 2003 Jan; 24(1):17-25. PubMed ID: 12516075
[TBL] [Abstract][Full Text] [Related]
6. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
7. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
8. Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: application of pharmacokinetic study in rats.
Ren HC; Sun JG; Wang GJ; A JY; Xie HT; Zha WB; Yan B; Sun FZ; Hao HP; Gu SH; Sheng LS; Shao F; Shi J; Zhou F
J Pharm Biomed Anal; 2008 Dec; 48(5):1476-80. PubMed ID: 19022601
[TBL] [Abstract][Full Text] [Related]
9. In vivo metabolism and final disposition of a novel nonsteroidal androgen in rats and dogs.
Perera MA; Yin D; Wu D; Chan KK; Miller DD; Dalton J
Drug Metab Dispos; 2006 Oct; 34(10):1713-21. PubMed ID: 16815963
[TBL] [Abstract][Full Text] [Related]
10. Quantitative LC/MS/MS method and pharmacokinetic studies of columbin, an anti-inflammation furanoditerpen isolated from Radix Tinosporae.
Shi Q; Liang M; Zhang W; Zhang C; Liu R; Shen Y; Li H; Wang X; Wang X; Pan Q; Chen C
Biomed Chromatogr; 2007 Jun; 21(6):642-8. PubMed ID: 17345572
[TBL] [Abstract][Full Text] [Related]
11. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.
Chan S; Edwards SR; Wyse BD; Smith MT
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):295-302. PubMed ID: 17973932
[TBL] [Abstract][Full Text] [Related]
13. Quantitative determination of the anticancer agent tubeimoside I in rat plasma by liquid chromatography coupled with mass spectrometry.
Liang MJ; Zhang WD; Zhang C; Liu RH; Shen YH; Li HL; Wang XL; Wang XW; Zhu JB; Chen CL
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jan; 845(1):84-9. PubMed ID: 16931181
[TBL] [Abstract][Full Text] [Related]
14. 1,2,3,4-Tetrahydroquinoline-containing alphaVbeta3 integrin antagonists with enhanced oral bioavailability.
Ghosh S; Santulli RJ; Kinney WA; Decorte BL; Liu L; Lewis JM; Proost JC; Leo GC; Masucci J; Hageman WE; Thompson AS; Chen I; Kawahama R; Tuman RW; Galemmo RA; Johnson DL; Damiano BP; Maryanoff BE
Bioorg Med Chem Lett; 2004 Dec; 14(23):5937-41. PubMed ID: 15501072
[TBL] [Abstract][Full Text] [Related]
15. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
16. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
17. New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans.
Trellu M; Filali-Ansary A; Françon D; Adam R; Lluel P; Dubruc C; Thénot JP
Fundam Clin Pharmacol; 2004 Aug; 18(4):493-501. PubMed ID: 15312157
[TBL] [Abstract][Full Text] [Related]
18. Application of stable isotope methodology in the evaluation of the pharmacokinetics of (S,S)-3-[3-(methylsulfonyl)phenyl]-1-propylpiperidine hydrochloride in rats.
Yamazaki S; Toth LN; Kimoto E; Bower J; Skaptason J; Romero D; Heath TG
Drug Metab Dispos; 2009 May; 37(5):937-45. PubMed ID: 19237512
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of sebacic acid in rats.
Favuzzi AM; Mingrone G; Bertuzzi A; Salinari S; Gandolfi A; Greco AV
Eur Rev Med Pharmacol Sci; 1999; 3(3):119-25. PubMed ID: 10827815
[TBL] [Abstract][Full Text] [Related]
20. Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application.
Wu JW; Lin LC; Hung SC; Chi CW; Tsai TH
J Pharm Biomed Anal; 2007 Nov; 45(4):635-41. PubMed ID: 17692492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
